Drug Shortage Report for VISKAZIDE
| Report ID | 256271 |
| Drug Identification Number | 00568635 |
| Brand name | VISKAZIDE |
| Common or Proper name | Pindolol and Hydrochlorothiazide |
| Company Name | XEDITON PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE PINDOLOL |
| Strength(s) | 50MG 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | Calendar packs of 35 |
| ATC code | C07CA |
| ATC description | BETA BLOCKING AGENTS AND OTHER DIURETICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2025-05-01 |
| Actual start date | 2025-05-01 |
| Estimated end date | 2025-08-31 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-05-02 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2020 WINSTON PARK DRIVE OAKVILLE, ONTARIO CANADA L6H 6X7 |
| Company contact information | [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2025-05-02 | English | Compare |
| v2 | 2025-05-01 | French | Compare |
| v1 | 2025-05-01 | English | Compare |
Showing 1 to 3 of 3